CLINICAL STUDIES
Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty
Randomized comparison of Inoue and double-balloon techniques
Duk-Hyun Kang, MDa,
Seong-Wook Park, MD, FACCa,
Jae-Kwan Song, MDa,
Hyun-Sook Kim, MDa,
Myeong-Ki Hong, MDa,
Jae-Joong Kim, MDa and
Seung-Jung Park, MD, FACCa
a Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan, Seoul, South Korea
Manuscript received February 1, 1999;
revised manuscript received July 22, 1999,
accepted September 13, 1999.
Reprint requests and correspondence: Dr. Seung-Jung Park, Department of Internal Medicine, University of Ulsan, Division of Cardiology, Asan Medical Center, Songpa-ku Poongnap-Dong 388-1, Seoul 138-736, Korea
sjpark{at}www.amc.seoul.kr
OBJECTIVES
The purpose of the present study was to compare the long-term clinical and echocardiographic results of the Inoue and the double-balloon techniques.
BACKGROUND
The large randomized trial comparing the extent of commissurotomy and the long-term results between the double-balloon and Inoue balloon techniques has not been reported.
METHODS
We conducted a prospective, randomized trial comparing two procedures in 302 consecutive patients who underwent percutaneous mitral valvuloplasty (PMV) using Inoue (n = 152; group I) or double-balloon technique (n = 150, group D) between 1989 and 1995. The sample size was planned to provide the study with approximately 80% power for the detection of a 10% difference between the two groups.
RESULTS
There were no significant differences in baseline characteristics between the two groups. Immediately after PMV, mitral valve area (MVA) increased from 0.9 ± 0.2 to 1.8 ± 0.3 cm2 in group I and from 0.9 ± 0.2 to 1.9 ± 0.3 cm2 in group D. No significant differences existed between the two groups in terms of development of commissural splitting, commissural mitral regurgitation (CMR), moderate to severe mitral regurgitation (MR) and MVA after PMV. The successful immediate results (MVA  1.5 cm2 and MR  2) were achieved in 127 (84%) patients of group I and 122 (81%) patients of group D (p = NS). Annual clinical and echocardiographic evaluation was completed for 290 (96%) patients with mean follow-up of 51 ± 27 months. Adverse events occurred in 19 (13%) patients of group I (3 deaths, 7 mitral valve replacements, 5 repeat PMV, 2 NYHA class 3, 2 technical failures) and 16 (11%) patients of group D (2 deaths, 10 mitral valve replacements, 3 repeat PMV, 1 NYHA class 3). Estimated actuarial seven-year event-free survival was 75 ± 7% in group I and 82 ± 6% in group D (p = NS). Estimated actuarial seven-year restenosis-free survival was 67 ± 7% in group I and 76 ± 6% in group D (p = NS). On multivariate analysis, unsuccessful immediate result (p < 0.001) and absence of CMR (p < 0.01) were independently related with events. Absence of CMR and smaller mitral valve area after PMV were independently related with restenosis (p < 0.001).
CONCLUSIONS
The Inoue and double-balloon techniques were equally effective in commissurotomy and produced similar, excellent long-term results. The achievement of complete commissurotomy with development of CMR or larger post-PMV mitral valve area is important to optimize the long-term results of PMV.
|
Abbreviations and Acronyms
| | BSA | = body surface area | | CMR | = commissural mitral regurgitation | | EBDA | = effective balloon dilating area | | group D | = double-balloon group | | group I | = Inoue balloon group | | MR | = mitral regurgitation | | MS | = mitral stenosis | | MVA | = mitral valve area | | NYHA | = New York Heart Association | | PMV | = percutaneous mitral valvuloplasty |
|
This article has been cited by other articles:
|
|
|
|
 
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
October 7, 2008;
118(15):
e523 - e661.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Song, D.-H. Kang, J. H. Kim, K.-M. Park, J.-M. Song, K.-J. Choi, M.-K. Hong, C. H. Chung, J.-K. Song, J.-W. Lee, et al.
Percutaneous Mitral Valvuloplasty Versus Surgical Treatment in Mitral Stenosis With Severe Tricuspid Regurgitation
Circulation,
September 11, 2007;
116(11_suppl):
I-246 - I-250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-J. Kim, J.-K. Song, J.-M. Song, D.-H. Kang, Y.-H. Kim, C. W. Lee, M.-K. Hong, J.-J. Kim, S.-W. Park, and S.-J. Park
Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral Valvuloplasty
Circulation,
December 19, 2006;
114(25):
2815 - 2822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
e1 - e148.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
598 - 675.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Carabello
Modern Management of Mitral Stenosis
Circulation,
July 19, 2005;
112(3):
432 - 437.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Iung, A. Nicoud-Houel, O. Fondard, H. Akoudad, T. Haghighat, E. Brochet, E. Garbarz, B. Cormier, G. Baron, P. Luxereau, et al.
Temporal trends in percutaneous mitral commissurotomy over a 15-year period
Eur. Heart J.,
April 2, 2004;
25(8):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.J. Ferguson
Moving beyond unfractionated heparin for acute coronary syndromes: Xeno's Paradox revisited
Eur. Heart J.,
February 2, 2002;
23(4):
264 - 268.
[Full Text]
[PDF]
|
|
|
|
